MedTrace Logo

Integrated Care Pathway in Oncology (PASSION)

NCT04235556 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1800

Last updated 2022-05-13

No results posted yet for this study

Summary

A centralized unit for integrated management of care pathway in Oncology has been created. This unit settles the patients' appointments (biopsy, intravenous device, chemotherapy, imaging, oncologist...).

The aim of this study is to assess the delay between the first appointment with the oncologist and the beginning of the antitumoral treatment, and therefore evaluate the efficacy of the care pathway unit.

The second aim is to assess the satisfaction of patients and health care teams.

Conditions

Interventions

BEHAVIORAL

Care pathway unit

Patients from the prospective cohort will have their health care scheduled by the care pathway unit.

Sponsors & Collaborators

  • MSD France

    collaborator INDUSTRY

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Virginie Bichon · AP-HP, Hôpital Européen Georges Pompidou, Paris

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-21
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04235556 on ClinicalTrials.gov